Analysis10k / Blog
EN한국어ES

All Posts

173 posts

LLY
Company Snapshot

Eli Lilly (LLY): What This Company Actually Does

A plain-English read of Eli Lilly's business model, built directly from its SEC filings — no hype, just where the money comes from.

2026-09-28
LLY
The Story

Eli Lilly's Last Three Years: A Company That Couldn't Keep Up With Its Own Success

How Mounjaro and Zepbound demand kept outrunning Eli Lilly's own guidance — and how the two moments that looked like trouble both turned into launching pads for the next raise.

2026-09-28
LLY
Reverse DCF

What LLY's Stock Price Is Really Betting On

Reverse-engineering the growth rate Eli Lilly's current share price already assumes — and why the answer swings wildly depending on which year's cash flow you use as a baseline.

2026-09-28
ABBV
Company Snapshot

AbbVie (ABBV): What This Company Actually Does

A plain-English read of AbbVie's business model, built directly from its SEC filings — no hype, just where the money comes from.

2026-09-27
ABBV
The Story

AbbVie's Last Three Years: 'Raising Guidance' While the Number Keeps Falling

How a CEO transition and a buying spree turned AbbVie's own guidance language into a puzzle worth decoding every quarter.

2026-09-27
ABBV
Reverse DCF

What ABBV's Stock Price Is Really Betting On

Reverse-engineering the growth rate AbbVie's current share price already assumes — and checking it against five years of shrinking free cash flow.

2026-09-27
LDOS
Company Snapshot

Leidos (LDOS): What This Company Actually Does

A plain-English read of Leidos' business model, built directly from its SEC filings — no hype, just where the money comes from.

2026-09-24
AIR
Company Snapshot

AAR Corp. (AIR): What This Company Actually Does

A plain-English read of AAR's business model, built directly from its SEC filings — no hype, just where the money comes from.

2026-09-24
AIR
Reverse DCF

What AIR's Stock Price Is Really Betting On

Reverse-engineering the growth rate AAR's current share price already assumes — and why a thin, volatile free-cash-flow base makes that number unusually large.

2026-09-24
AIR
The Story

AAR Corp.'s Last Three Years: A $55.6 Million Settlement and a Corporate Makeover

How a foreign-bribery settlement and a criminal case against its own CEO coincided with the company cutting its slowest-growing businesses and doubling down on M&A.

2026-09-24
MRCY
Reverse DCF

What MRCY's Stock Price Is Really Betting On

Reverse-engineering the growth rate Mercury Systems' current share price already assumes — and checking it against a business that's barely grown its top line.

2026-09-24
KTOS
Company Snapshot

Kratos Defense (KTOS): What This Company Actually Does

A plain-English read of Kratos's business model, built directly from its SEC filings — no hype, just where the money comes from.

2026-09-24